Therefore, our data might suggest a decrease of IDO activity within IS of COPD compared to the asthmatic patients, which resulted in the observed lower levels of 6-hydroxykynurenic acid in COPD compared to asthma. The gene discussed is IDO1; the disease is chronic obstructive pulmonary disease.